197 related articles for article (PubMed ID: 6244869)
21. Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma.
Mukojima T; Gunvén P; Klein G
J Natl Cancer Inst; 1973 Oct; 51(4):1319-21. PubMed ID: 4355608
[No Abstract] [Full Text] [Related]
22. EBV-positive Burkitt's lymphoma from Algeria, with a three-way rearrangement involving chromosomes 2, 8 and 9.
Philip T; Lenoir GM; Fraisse J; Philip I; Bertoglio J; Ladjaj S; Bertrand S; Brunat-Mentigny M
Int J Cancer; 1981 Oct; 28(4):417-20. PubMed ID: 6273331
[TBL] [Abstract][Full Text] [Related]
23. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA.
Takada K; Horinouchi K; Ono Y; Aya T; Osato T; Takahashi M; Hayasaka S
Virus Genes; 1991 Apr; 5(2):147-56. PubMed ID: 1647567
[TBL] [Abstract][Full Text] [Related]
24. Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma.
Granlund DJ; Nkrumah F; Perkins IV; Biggar RJ; Levine PH; Fuccillo DA
Int J Cancer; 1979 Nov; 24(5):567-71. PubMed ID: 231015
[TBL] [Abstract][Full Text] [Related]
25. An Epstein-Barr virus-negative B lymphoma cell line (THP-2) from a Burkitt's lymphoma of a Japanese patient.
Tsuchiya S; Yamaguchi Y; Kobayashi Y; Minegishi M; Imaizumi M; Suzuki H; Konno T; Tada K
Tohoku J Exp Med; 1983 Aug; 140(4):429-34. PubMed ID: 6314596
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma.
Hirshaut Y; Cohen MH; Stevens DA
Lancet; 1973 Jul; 2(7821):114-6. PubMed ID: 4124041
[No Abstract] [Full Text] [Related]
27. Antibodies to Epstein-Barr virus associated antigens in Burkitt's lymphoma.
Gunvén P; Klein G; Henle G; Henle W; Clifford P; Singh S
Bibl Haematol; 1973; 39():813-7. PubMed ID: 4360196
[No Abstract] [Full Text] [Related]
28. Epstein-Barr virus (EBV) hypersensitivity of peripheral B lymphocytes in patients with EBV genome-positive Burkitt's lymphoma.
Okano M; Mizuno F; Osato T
J Infect; 1995 Jul; 31(1):15-9. PubMed ID: 8522826
[TBL] [Abstract][Full Text] [Related]
29. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
[TBL] [Abstract][Full Text] [Related]
30. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
Henle W; Henle G
Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
[No Abstract] [Full Text] [Related]
31. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
Gunvén P; Klein G; Clifford P; Singh S
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538
[TBL] [Abstract][Full Text] [Related]
32. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
Gunvén P
Hamatol Bluttransfus; 1974; 14():129-32. PubMed ID: 4375070
[No Abstract] [Full Text] [Related]
33. A Danish adult case of EBV-positive Burkitt's lymphoma.
Laulund S; Elling F; Saemundsen AK
Acta Pathol Microbiol Immunol Scand A; 1983 Jan; 91(1):77-80. PubMed ID: 6299057
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menezes J; Leibold W; Klein G; Clements G
Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
[TBL] [Abstract][Full Text] [Related]
35. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda.
Olweny CL; Atine I; Kaddu-Mukasa A; Owor R; Andersson-Anvret M; Klein G; Henle W; de-Thé G
J Natl Cancer Inst; 1977 May; 58(5):1191-6. PubMed ID: 192894
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
Magrath I; Henle W; Owor R; Olweny C
N Engl J Med; 1975 Mar; 292(12):621-3. PubMed ID: 163432
[No Abstract] [Full Text] [Related]
38. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
Morrow RH; Sever JL; Henderson BE
Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
[No Abstract] [Full Text] [Related]
39. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies.
Sternås L; Luka J; Kallin B; Rosén A; Henle W; Henle G; Klein G
J Immunol Methods; 1983 Oct; 63(2):171-85. PubMed ID: 6311908
[TBL] [Abstract][Full Text] [Related]
40. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
Okano M; Aya T; Mizuno F; Takada K; Osato T
Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
